Drug Farm Reports Safety Data from Phase 1 Trial of DF-003
29 May 2025 //
BUSINESSWIRE
Drug Farm, Xiamen Amoytop Biotech Co. Sign Option for Df-006
27 May 2025 //
BUSINESSWIRE
Drug Farm Gets FDA IND Clearance For ROSAH DF-003 Phase 1b
17 May 2024 //
BUSINESSWIRE
Drug Farm`s DF-006 Accepted For EASL 2024 Late-Breaker
02 May 2024 //
BUSINESSWIRE
Drug Farm Doses First Patient in Part 3 of Phase 1 Chronic Hepatitis B Trial
26 Sep 2023 //
BUSINESSWIRE